Cartesian Therapeutics Statistics
NASDAQ: RNACHealthcareBiotechnologyUSD
6.68-0.07 (-1.04%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Cartesian Therapeutics by the numbers
Cartesian Therapeutics has a market capitalization of $202.1 million based on 30.26M shares outstanding. With trailing EPS of $-5.78, Cartesian Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 21.3% below its 50-day average and 13.3% below its 200-day average.
Average daily trading volume is 132.71K shares, or about $886,530 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
RNAC valuation vs. peer median
| Metric | RNAC | Peer median | Difference |
|---|---|---|---|
| Market cap | $202.11M | $206.71M | -2% |
| Avg. volume | 132.71K | 660.16K | -80% |
Peer median across 8 companies: CGEN, LYEL, ACOG, ELDN, WHWK, ALEC, IVVD, SION.
Valuation
- Market cap
- $202.11M
- EPS (TTM)
- $-5.78
- Shares outstanding
- 30.26M
Price and trading
- Previous close
- 6.75
- Open
- 6.70
- Day range
- 6.60 – 6.84
- 52-week range
- 5.60 – 11.00
- 52-week change
- -31.42%
- Beta
- —
- Volume
- 86.41K
- Average volume
- 132.71K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 202.11M
- Forward Pe
- -1.75
- Eps
- -5.78
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 11.00
- Week52 Low
- 5.60
- Avg Volume
- 132.71K
- Shares Outstanding
- 30.26M
- Ma50
- 8.49
- Ma200
- 7.71
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -39.27%
- Pct From52w Low
- 19.29%